La biotech Abivax accorde une période d'exclusivité à AstraZeneca en vue d'un rachat - LA LETTRE La start-up française dirigée par Marc de Garidel donne jusqu'au 23 mars au géant pharmaceutique britannique un accès exclusif à des informations confidentielles pour qu'il formalise son offre de

La biotech #Abivax dirigée par Marc de Garidel donne à #AstraZeneca un accès exclusif à des informations confidentielles pour qu'il formalise son offre de rachat

Passé ce délai, Abivax sera libre d'engager des discussions avec les autres prétendants
www.lalettre.fr/fr/entrepris...

Inédito: recibe la Presidenta Sheinbaum a más de 100 directivos ejecutivos de empresas nórdicas - Hans Digital La delegación encabezada por Grupo Wallenberg, reunió a líderes como Ericsson, Volvo, Lego, Maersk y AstraZeneca, entre otros, que generan ingresos superiores a 385 mil mdd y operan en cerca de 180 pa...

🛑Inédito: recibe la Presidenta #Sheinbaum a más de 100 directivos ejecutivos de #empresas nórdicas encabezados por Grupo Wallenberg, Reunió a líderes como #Ericsson, #Volvo, #lego, #Maersk, #Nokia y #AstraZeneca, entre otros; generan ingresos superiores a 385 mil mdd y operan en cerca de 180 países

32-34 NEW PHARMA - In therapies PharmaTimes March explores today's life sciences landscape: patient autonomy where access to medicines is expected. Shifting politics, "super employees," ongoing innovation, GLP-1s, difficult-to-treat...

#obesity #diabetes #typeIIdiabetes #oncology #neurology #rarediseases #womenshealth #EliLilly #Akeso #SummitTherapeutics #precisionmedicine #immunotherapy #Alzheimersdisease #AstraZeneca #DaiichiSankyo #ADCs #precisiononcology #DrugstoWatch2026 #immunology #cardiology #CGTs
zurl.co/c8PJw

AstraZeneca muss Auskunft geben Eine Zahnärztin hat mit ihrer Klage vor dem BGH gegen AstraZeneca einen Teilerfolg erreicht.

AstraZeneca muss Auskunft geben #AstraZeneca #Covid #Bundesgerichtshof

Wann Impfstoffhersteller haften Vor dem Bundesgerichtshof geht es heute um mögliche Ansprüche nach einer Corona-Impfung.

Wann Impfstoffhersteller haften #FAQ #AstraZeneca #Corona-Impfung

Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

Up and Down the Ladder: Job Changes.. the latest comings & goings.. recognize anyone? statnews.com/pharmalot/20... #pharma #biotech #jobs #GSK #AbbVie #Takeda #AstraZeneca

Compugen Achieves Significant Milestones in Q4 and Full Year 2025 Financial Results Compugen announces strong financial results for Q4 and the full year of 2025, highlighting strategic partnerships and operational advancements.

Compugen Achieves Significant Milestones in Q4 and Full Year 2025 Financial Results #Israel #AstraZeneca #Compugen #Holon #Gilead

PLEASE SHARE ⬇️
There is a lot of FAKE NEWS being spead about #HannahSpencer from @greenparty.org.uk recently elected MP of #GortonSndDenton
FACT ✅
She is a plumber and plasterer and NOT married
FAKE ❎
She is NOT married to a multimillionaire chief executive at #AstraZeneca.

Lung Cancer Research Foundation and AstraZeneca Collaborate on Small Cell Lung Cancer Grants The Lung Cancer Research Foundation, in collaboration with AstraZeneca, unveils grants focused on advancing treatments for small cell lung cancer.

Lung Cancer Research Foundation and AstraZeneca Collaborate on Small Cell Lung Cancer Grants #United_States #New_York #AstraZeneca #Research_Grants #Lung_Cancer

Sehr spannend und hörenswert!
music.amazon.de/podcasts/54d...
#Aufarbeitung #AstraZeneca #Pandemia #Podcast

🌍 Europe stocks rise despite US-Iran tensions.
💊 AstraZeneca's Calquence wins FDA approval.
🛢️ Tullow Oil gains on better finances.
#StockMarket #Europe #AstraZeneca #TullowOil
View in Timelines

AstraZeneca raises guidance on stellar cancer drugs growth AZ reports strong financial results for 2025, and provides a first peek at the data for its oral GLP-1 contender elecoglipron

#AstraZeneca #PascalSoriot #cancertherapies #oncologyproducts #commercialperformance #blockbusterbrands #cancer #weightloss #genetherapies #antiHER2therapy #prostatecancer #breastcancer #asthma #respiratorysyncytialvirus #RSV #RSVprophylactic #lupus #phase2trials #phase3trials
zurl.co/yLEDf

El hub global d’AstraZeneca a Barcelona, reconegut com un dels 5 millors projectes d’inversió estrangera a Europa pel grup Financial Times
#Notesdepremsa #AstraZeneca #Innovaci #Recerca #Barcelona […]

En dit is het artikel in science over de bedoelde ernstige en zeer zeldzame bijwerkingen van de hieronder genoemde vaccins.
#AstraZeneca #JohnsonJohnson #COVID19

bsky.app/profile/kaka...

AstraZeneca bladder cancer therapy wins NICE backing - PharmaTimes Regulator recommends durvalumab as first perioperative IO option for muscle‑invasive disease

#AstraZeneca #bladdercancer #NICE #NICErecommended #durvalumab #perioperativeIOtreatment #perioperativeimmuneoncologytreatment #muscleinvasivebladdercancer #Niagaraphase3trial #bladdercancerpatients #innovativemedicine #JeannieRigby #bladdercancercare #perioperativeDurvalumab
zurl.co/U8lNl

AstraZeneca - Research-Based BioPharmaceutical Company AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.

#AZN 🆙+1%✅ £140.40✅
MT #AstraZeneca
✅2025 was another year of strong growth with excellent pipeline delivery across all therapy areas and major regions.

✅Learn more here about our FY 2025 results learn.az/6013h3PrH

😊I continue to hold $AZN & compounding their #dividends for 32 yrs👍

SEB om #AstraZeneca

Continued portfolio delivery drives growth for AstraZeneca during a catalyst-rich period. The company reports full-year 2025 product sales of USD 55,573 million, up 9% at constant exchange rates. #AstraZeneca #LifeScience

Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

Up and Down the Ladder: Job Changes.. the latest comings & goings.. recognize anyone? statnews.com/pharmalot/20... #pharma #biotech #jobs #AstraZeneca #NovoNordisk

Astounding Market Movements: AstraZeneca's Historic NYSE Transfer and Pre-Market Insights In a thrilling pre-market update, AstraZeneca's shares make waves on the NYSE following a monumental transfer, amidst mixed investor reactions.

Astounding Market Movements: AstraZeneca's Historic NYSE Transfer and Pre-Market Insights #USA #New_York #AstraZeneca #NYSE #Market_Insights

#FDA has delivered a setback to #AstraZeneca by rebuffing its new formulation of lupus therapy Saphnelo, which was approved in Europe last year.

pharmaphorum.com/news/fda-kno...

AstraZeneca's Record Trading Begins on NYSE Amid Market Volatility AstraZeneca's ordinary shares start trading on NYSE, marking a record transfer. The stock market faces volatility, impacting major indices.

AstraZeneca's Record Trading Begins on NYSE Amid Market Volatility #United_States #New_York #AstraZeneca #Trading #NYSE

The first immunotherapy-based perioperative therapy for gastric cancer is nearing EU approval. CHMP recommended AstraZeneca's Imfinzi based on Phase III data showing a 29% reduction in the risk of progression, recurrence, or death. #AstraZeneca #BioStock

AstraZeneca conclut un accord d’une valeur de 18,5 milliards de dollars avec une société pharmaceutique chinoise pour des médicaments contre l’obésité Principaux renseignements AstraZeneca, géant pharmaceutique anglo-suédois, a conclu un accord de licence important avec le groupe pharmaceutique chinois CSPC, d’une valeur pouvant atteindre 18,5 milliards de dollars (15,5 milliard d’euros). Cet accord accorde à AstraZeneca les droits exclusifs de développement et de commercialisation de médicaments expérimentaux ciblant l’obésité et les troubles du poids associés. Détails […]

AstraZeneca conclut un accord d’une valeur de 18,5 milliards de dollars avec une société pharmaceutique chinoise pour des médicaments contre l’obésité #AstraZeneca #Obésité #Pharmaceutique #Médicaments #Chine

AstraZeneca sluit overeenkomst ter waarde van 18,5 miljard dollar met Chinees farmabedrijf voor geneesmiddelen tegen obesitas Key takeaways AstraZeneca, een Brits-Zweedse farmagigant, heeft een belangrijke licentieovereenkomst gesloten met de Chinese CSPC Pharmaceutical Group ter waarde van maximaal 18,5 miljard dollar (15,5 miljard euro). Die overeenkomst verleent AstraZeneca exclusieve rechten voor de ontwikkeling en commercialisering van experimentele geneesmiddelen tegen obesitas en aanverwante gewichtsproblemen. Financiële details van de overeenkomst De overeenkomst omvat een […]

AstraZeneca sluit overeenkomst ter waarde van 18,5 miljard dollar met Chinees farmabedrijf voor geneesmiddelen tegen obesitas #AstraZeneca #obesitas #gezondheid #farmacie #medicijnen

Levy tobacco companies to fund national community pharmacy ‘stop smoking’ service, says report Government should consider funding a national community pharmacy walk-in ‘stop smoking’ service through a levy on tobacco companies, according to a report published by AstraZeneca. A ‘polluter pays’…

Recommendations made by #AstraZeneca in partnership with several pharmacy bodies have called for tobacco companies to fund a national community pharmacy walk-in ‘stop smoking’ service

#CVD #CVDpolicy #healthandcarepolicy #smoking #smokingcessation

Pharmalittle: We're reading about TrumpRx questions, drugmakers lowering some prices, and more Three U.S. senators sent a letter to the HHS Office of Inspector General raising questions about TrumpRx — whose structure has yet to be detailed

Pharmalot.. Pharmalittle: We’re reading about TrumpRx questions, drugmakers lowering some prices, and more news.. statnews.com/pharmalot/20... #pharma #Trump #telehealth #obesity #insulin #PBM #China #AstraZeneca

#AstraZeneca is already deeply embedded in #China's pharma sector, and is hungry for more, pledging $15 billion to an #investment programme in the country and signing a mammoth #licensing deal with Hong Kong-listed #CSPCPharma.

pharmaphorum.com/news/az-deep...

AstraZeneca expands its focus on metabolic diseases through a new licensing deal with CSPC Pharmaceuticals. The company gains rights to a once-monthly injectable weight management portfolio entering Phase I, plus preclinical assets for obesity and diabetes. #AstraZeneca #Obesity